A somatic mutation of GFI1B identified in leukemia alters cell fate via a SPI1 (PU.1) centered genetic regulatory network

被引:18
作者
Anguita, Eduardo [1 ]
Gupta, Rajeev [2 ]
Olariu, Victor [3 ]
Valk, Peter J. [4 ]
Peterson, Carsten [3 ]
Delwel, Ruud [4 ]
Enver, Tariq [2 ]
机构
[1] Hosp Clin San Carlos IdISSC, Dept Hematol, Prof Martin Lagos S-N, Madrid 28040, Spain
[2] UCL Canc Inst, Paul OGorman Bldg 72 Huntley St, London WC1E 6BT, England
[3] Lund Univ, Computat Biol & Biol Phys Div, Lund, Sweden
[4] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands
关键词
GFI1B; SPI1; PU.1; Transcriptional networks; Acute myeloid leukemia; Myelodysplastic syndrome; TRANSCRIPTION FACTOR-BINDING; ZINC-FINGER PROTEIN; HEMATOPOIETIC STEM; GFI-1B; EXPRESSION; DIFFERENTIATION; NEUTROPENIA; REQUIREMENT; MACROPHAGE; REPRESSION;
D O I
10.1016/j.ydbio.2016.02.002
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We identify a mutation (D262N) in the erythroid-affiliated transcriptional repressor GFI1B, in an acute myeloid leukemia (AML) patient with antecedent myelodysplastic syndrome (MDS). The GFI1B-D262N mutant functionally antagonizes the transcriptional activity of wild-type GFI1B. GFI1B-D262N promoted myelomonocytic versus erythroid output from primary human hematopoietic precursors and enhanced cell survival of both normal and MDS derived precursors. Re-analysis of AML transcriptome data identifies a distinct group of patients in whom expression of wild-type GFI1B and SPIT (PU.1) have an inverse pattern. In delineating this GFI1B-SPI1 relationship we show that (i) SPI1 is a direct target of GFI1B, (ii) expression of GFI1B-D262N produces elevated expression of SPI1, and (iii) SPIT-knockdown restores balanced lineage output from GFI1B-D262N-expressing precursors. These results table the SPI1-GFI1B transcriptional network as an important regulatory axis in AML as well as in the development of erythroid versus myelomonocytic cell fate. (C) 2016 Published by Elsevier Inc.
引用
收藏
页码:277 / 286
页数:10
相关论文
共 52 条
[51]   PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway [J].
Zhou, J. ;
Wu, J. ;
Li, B. ;
Liu, D. ;
Yu, J. ;
Yan, X. ;
Zheng, S. ;
Wang, J. ;
Zhang, L. ;
Zhang, L. ;
He, F. ;
Li, Q. ;
Chen, A. ;
Zhang, Y. ;
Zhao, X. ;
Guan, Y. ;
Zhao, X. ;
Yan, J. ;
Ni, J. ;
Nobrega, M. A. ;
Loewenberg, B. ;
Delwel, R. ;
Valk, P. J. M. ;
Kumar, A. ;
Xie, L. ;
Tenen, D. G. ;
Huang, G. ;
Wang, Q-f .
LEUKEMIA, 2014, 28 (07) :1436-1448
[52]  
ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024